Octavio Ballesta-López
10PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Feb 26, 2025
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.Octavio Ballesta-López, Mayte Gil-Candel, María Centelles-Oria
|Jan 28, 2023
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape.Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López
|Apr 23, 2022
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study.Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López
|Jan 25, 2022
Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia.Antonio Solana-Altabella, Octavio Ballesta-López, Juan Eduardo Megías-Vericat
|Jul 29, 2021
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.Rubén Iglesias Gómez, Raúl Méndez, Tomás Palanques-Pastor
|May 08, 2021
Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain.Blanca Boluda, Antonio Solana-Altabella, Isabel Cano
Pageof 2
Frequent Collaborators
9 joint publications
Juan Eduardo Megías-Vericat
7 joint publications
Antonio Solana-Altabella
6 joint publications
Pau Montesinos
6 joint publications
David Martínez-Cuadrón
3 joint publications
Blanca Boluda
3 joint publications
MiguelÁngel Sanz
2 joint publications
José Luis Poveda-Andrés
1 joint publications
Juan Montoro Gómez
1 joint publications
Rubén Iglesias Gómez
1 joint publications
Tomás Palanques-Pastor
